Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 13.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 33.50
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 0
  • Market Cap: £54.65m

Latest Deals

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £721,783
Christopher Paul Hancock 4,838,793 £641,140
Richard John Rees 3,050,676 £404,215
Craig Jonathan Gulliford 1,666,907 £220,865
David Gerard Woods 440,255 £58,334
Charles Spicer 308,530 £40,880
Ivonne Cantu 125,000 £16,562

Major Shareholders

Notifier** Holding Value*
M&G Investments 47,478,836 £6,290,946
Canaccord Genuity Group Inc 36,014,293 £4,771,894
River Global Investors LLP 20,827,081 £2,759,588
Development Bank of Wales plc 14,376,727 £1,904,916
Finance Wales 12,776,727 £1,692,916
Baillie Gifford & Co 12,537,441 £1,661,211
Creo Medical Group EBT 10,000,000 £1,325,000
The Capital Group Companies, Inc. 8,816,807 £1,168,227
AXA Framlington Investment Managers 7,992,961 £1,059,067
Hargreave Hale Limited 6,753,632 £894,856
Tellworth Investments 5,772,778 £764,893
Hoya Corporation 4,799,880 £635,984
Jonathan Craton 3,400,294 £450,539
Cotterford Co Limited 3,335,398 £441,940
Mark Farmer 3,121,607 £413,613
RBC Trustees (CI) Ltd 2,974,727 £394,151
Angel Co Fund 2,967,120 £393,143

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 13.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 33.50
52 Week Low 9.55
Volume 0
Shares Issued 412.47m
Market Cap £54.65m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.14% above the market average5.14% above the market average5.14% above the market average5.14% above the market average5.14% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Price Trend
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Income Not Available
Growth
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page